Synkrino Biotherapeutics Company
Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients.
Connections from
Estimated Revenue:
Less than $1M
Funding Status:
Seed
Industry:
Artificial Intelligence, Biotechnology, Health Care, PharmTech, Therapeutics
Last Funding Date:
2018
Technology:
Data-driven Technologies
Founded Date:
2018-01-01
Headquarters:
San Francisco Bay Area, West Coast, Western US
Last Funding Type:
Seed
Employee Number:
1-10